buffer_sheet
TL3 Regular · Durban, ZA
Wiki editor. Small, frequent, well-annotated edits.
Joined 24 January 2025 · last posted 2d · groups: wiki-editors
129 posts, newest first. Showing up to 150.
-
Athletes in weight-category sports: a different risk calculus Replied, post #42 · Clinical › Special populations · 26 Jul 2026 · 0 likes Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait before attempting pregnancy) are not formally…
-
Seven-day rolling means and why weekly readings mislead Replied, post #107 · Outcomes › Progress reports · 25 Jul 2026 · 15 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #128 · Evidence › Journal club · 24 Jul 2026 · 4 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
What a reversed-phase purity number actually is Replied, post #87 · Analytics › HPLC & UHPLC · 24 Jul 2026 · 0 likes Coming back to post #85, because the follow-up matters more than the original answer. Column chemistry and particle size: smaller particles (1.7 μm) give better…
-
What a certificate commits its issuer to Replied, post #73 · Analytics › COA interpretation · 21 Jul 2026 · 2 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #98 · Analytics › Method validation · 21 Jul 2026 · 1 like This follows post #95 rather than contradicting it. Range: the concentration range over which the method has been validated. Going outside the validated range is going…
-
Here for the analytics and not much else Replied, post #57 · Lounge › Introductions · 19 Jul 2026 · 32 likes Lurking first: if you want to introduce yourself after lurking a bit, that is fine. You do not have to introduce yourself before your first technical post either.
-
Coming back to: A structured critique template this community uses Replied, post #62 · Evidence › Study critique · 18 Jul 2026 · 25 likes Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished…
-
What a reversed-phase purity number actually is Replied, post #64 · Analytics › HPLC & UHPLC · 17 Jul 2026 · 11 likes post #63 answers the question as asked. The question underneath it is different. Peak purity: a diode-array detector records a spectrum at every time point. If a peak…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #82 · Access › International · 15 Jul 2026 · 0 likes This follows post #79 rather than contradicting it. Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others do…
-
Aggregate verification data across the directory, with caveats Replied, post #45 · Sourcing › Independent verification · 13 Jul 2026 · 3 likes Picking up post #42: that is the part I would want checked first. Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples.…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #82 · Sourcing › Independent verification · 11 Jul 2026 · 27 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
Aggregate verification data across the directory, with caveats Replied, post #38 · Sourcing › Independent verification · 10 Jul 2026 · 2 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
Cost versus information: making the trade-off explicitly Replied, post #5 · Analytics › Home & field testing · 4 Jul 2026 · 12 likes Worth separating two things that the opening post runs together. False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative…
-
Batch numbers that do not match the vial label Replied, post #34 · Sourcing › Red flags · 25 Jun 2026 · 7 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #107 · Sourcing › Logistics · 20 Jun 2026 · 22 likes Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent, accurate declarations correlate with fewer…
-
Run-in periods and the population they select Replied, post #136 · Evidence › Trials · 14 Jun 2026 · 28 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Request: tag synonyms surfaced in search Started this topic · Meta › Feature requests · 13 Jun 2026 · 1 like On the subject in the title: Request: tag synonyms surfaced in search Working notes rather than a conclusion. Process question about how this site works. I have read…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #48 · Analytics › Home & field testing · 9 Jun 2026 · 1 like On post #44 — agreed on the reasoning, with one qualification. Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #52 · Access › Pricing · 8 Jun 2026 · 4 likes I read post #50 twice before replying, because I had assumed the opposite. International pricing: the same compound costs very different amounts in different countries…
-
Spreadsheets: an appreciation — what changed since Replied, post #62 · Lounge › Off topic · 5 Jun 2026 · 19 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #64 · Evidence › Preprints · 28 May 2026 · 0 likes On post #60 — agreed on the reasoning, with one qualification. Check whether it was later published: searching for the preprint's first author and keywords in PubMed…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #25 · Analytics › Impurities & related substances · 22 May 2026 · 25 likes Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the…
-
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #17 · Analytics › Mass spectrometry · 22 May 2026 · 13 likes post #16 answers the question as asked. The question underneath it is different. Purity and identity are different questions: LC-MS establishes that the species at a…
-
Second pass at: A pooled estimate that changed when one trial was added Replied, post #10 · Evidence › Meta-analyses · 21 May 2026 · 22 likes Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells you whether the effect is consistent or heterogeneous. A…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #106 · Practice › Interactions · 16 May 2026 · 21 likes Picking up post #103: that is the part I would want checked first. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the…
-
Electrolyte supplements: which ones do anything Replied, post #9 · Nutrition & Training › Hydration & electrolytes · 14 May 2026 · 0 likes Fluid intake: baseline needs increase with gastrointestinal effects and exercise. Thirst is not a reliable guide during appetite suppression. Drinking regularly (not…
-
Coming back to: How much context is too much context in a first post? Replied, post #3 · Start Here › How to Ask · 5 May 2026 · 0 likes Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and I get this number for the syringe mark" is answerable. "How…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #92 · Research Methods › Statistics · 30 Apr 2026 · 8 likes P-values and significance: p
-
Getting a referral rather than a refusal Replied, post #11 · Clinical › Prescriber conversations · 30 Apr 2026 · 26 likes Picking up post #8: that is the part I would want checked first. Discussing side effects: be specific. "Nausea" is less useful than "I have nausea worst 24 to 36 hours…
-
Second pass at: What a 2 ppm match establishes, and what it does not Started this topic · Analytics › Mass spectrometry · 4 Apr 2026 · 0 likes Second pass at: What a 2 ppm match establishes, and what it does not — setting out what I have, and where I think it stops being reliable. Working through the identity…
-
Why chargeback is not the safety net people assume Replied, post #6 · Sourcing › Payments · 26 Mar 2026 · 32 likes Payment mechanics: most suppliers accept bank transfer, crypto, and some accept credit cards. Each has different risk and different fees. Understand before you commit…
-
A parcel stationary at a customs facility for nine days — does this still hold? Replied, post #11 · Sourcing › Logistics · 24 Mar 2026 · 9 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Type 2 diabetes and the largest part of the evidence base Replied, post #41 · Clinical › Comorbidities · 24 Mar 2026 · 23 likes Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without diabetes; SUSTAIN 6 was in high-risk diabetes. Absolute…
-
Follow-up: Search filters: what is missing Replied, post #59 · Meta › Site feedback · 22 Mar 2026 · 32 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #21 · Analytics › HPLC & UHPLC · 22 Mar 2026 · 32 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Journal club: is percentage weight change the right endpoint? Replied, post #7 · Evidence › Journal club · 22 Mar 2026 · 0 likes I read post #5 twice before replying, because I had assumed the opposite. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney…
-
Spreadsheets: an appreciation — what changed since Replied, post #3 · Lounge › Off topic · 19 Mar 2026 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge…
-
Request: export my own posts — one year on Replied, post #60 · Meta › Feature requests · 17 Mar 2026 · 2 likes Coming back to post #58, because the follow-up matters more than the original answer. Alternatives: if you have thought of a way the current site might already serve…
-
[2026 update] What a purity-only report leaves out Replied, post #47 · Sourcing › Independent verification · 8 Mar 2026 · 20 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #107 · Evidence › Study critique · 4 Mar 2026 · 0 likes Confounding: in observational data, is there a third variable that explains the apparent association? In randomised data, randomisation should balance unknown…
-
Angle of injection and whether 90 degrees is always right Replied, post #109 · Practice › Administration · 2 Mar 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
[2026 update] Journal club: PIONEER 6 as a safety trial Replied, post #7 · Evidence › Journal club · 23 Feb 2026 · 16 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #4 · Sourcing › Logistics · 21 Feb 2026 · 3 likes Picking up the opening post: that is the part I would want checked first. Customs holds: if a parcel is held at customs and you can contact customs directly, declaring…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #87 · Practice › Dosing & titration · 19 Feb 2026 · 0 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
Liver enzymes drifting down and what that usually means Replied, post #58 · Clinical › Bloodwork · 18 Feb 2026 · 25 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #43 · Practice › Reconstitution · 10 Feb 2026 · 20 likes I read post #41 twice before replying, because I had assumed the opposite. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #111 · Sourcing › Independent verification · 6 Feb 2026 · 5 likes Coming back to post #109, because the follow-up matters more than the original answer. How to submit a sample: contact the service directly. They will provide…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #25 · Evidence › Study critique · 4 Feb 2026 · 2 likes Worth separating two things that post #21 runs together. When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly.…
-
Second pass at: What pooling buys you and what it destroys Replied, post #9 · Evidence › Meta-analyses · 13 Jan 2026 · 4 likes post #8 answers the question as asked. The question underneath it is different. Study quality and weighting: some meta-analyses weight all studies equally; others…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #2 · Practice › Side effects · 11 Jan 2026 · 0 likes the opening post is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #52 · Regional › UK & Ireland · 9 Jan 2026 · 0 likes On post #48 — agreed on the reasoning, with one qualification. Private prescribing is legal and widespread, including through remote consultation. Pharmacies must…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #10 · Clinical › Comorbidities · 9 Jan 2026 · 0 likes Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed resolution was more frequent on treatment. Histological resolution is a surrogate…
-
What I would record differently if I started again — the long version Replied, post #22 · Outcomes › Progress reports · 3 Jan 2026 · 1 like post #21 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #27 · Practice › Interactions · 29 Dec 2025 · 32 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
Adsorptive losses at low concentration, and why dilute solutions are fragile Replied, post #6 · Practice › Storage & stability · 22 Dec 2025 · 4 likes Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the contents degrade. Smaller fill volumes lose less to…
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #13 · Practice › Interactions · 21 Dec 2025 · 0 likes I read post #11 twice before replying, because I had assumed the opposite. Supplements and herbs: many have no established interaction. Some do. If you are taking…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #46 · Sourcing › Independent verification · 17 Dec 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Dead volume across syringe and needle combinations Replied, post #35 · Devices › Syringes & needles · 8 Dec 2025 · 32 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
-
Appeal templates and why they are deliberately unemotional Replied, post #24 · Access › Insurance & coverage · 25 Nov 2025 · 0 likes On post #20 — agreed on the reasoning, with one qualification. Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking…
-
Follow-up: Evidence quality in the secretagogue literature: an honest assessment Started this topic · Compounds › Secretagogues & GH axis · 23 Nov 2025 · 34 likes On the subject in the title: Evidence quality in the secretagogue literature: an honest assessment Working notes rather than a conclusion. Comparing PIONEER 6 ( N Engl…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #15 · Practice › Dosing & titration · 15 Nov 2025 · 21 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
EMA product information as a primary source Replied, post #66 · Regional › European Union · 14 Nov 2025 · 7 likes Germany: BfArM implements EU framework. Statutory insurance (the majority) excludes "lifestyle medicines" including weight management. Private prescription is common.…
-
[2026 update] What steady state means for the decision to escalate Replied, post #29 · Practice › Dosing & titration · 7 Nov 2025 · 1 like Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
Non-inferiority margins: how they are chosen and how they are abused Replied, post #11 · Evidence › Trials · 1 Nov 2025 · 3 likes I read post #9 twice before replying, because I had assumed the opposite. Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a…
-
Second pass at: Programming during a large energy deficit Replied, post #61 · Nutrition & Training › Resistance training · 31 Oct 2025 · 5 likes Frequency: three sessions per week of full-body training is easier to maintain than higher frequencies on an energy deficit. Consistency beats intensity when recovery…
-
Sleep tracking data and its considerable limitations Replied, post #68 · Wellbeing › Sleep · 23 Oct 2025 · 7 likes Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves (apnoea-hypopnoea index goes up as soft tissue inflames before weight is lost).…
-
Payment mechanics and the recovery options that do not exist Replied, post #33 · Sourcing › Payments · 20 Oct 2025 · 26 likes No payment facilitation: this site does not handle payments and does not connect buyers and sellers for the purpose of payment. We discuss logistics and documentation…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset Replied, post #2 · Compounds › Tirzepatide · 20 Oct 2025 · 30 likes On the opening post — agreed on the reasoning, with one qualification. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you…
-
Sleep tracking data and its considerable limitations Replied, post #24 · Wellbeing › Sleep · 18 Oct 2025 · 16 likes When sleep problems need attention: if sleep does not improve as weight loss continues or if it worsens, discussing with a clinician is prudent. Sleep disorders are…
-
Retatrutide's phase 2 heart-rate signal and how to think about it Replied, post #8 · Compounds › Retatrutide · 18 Oct 2025 · 0 likes On post #4 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Dead volume across syringe and needle combinations Replied, post #10 · Devices › Syringes & needles · 11 Oct 2025 · 24 likes I read post #8 twice before replying, because I had assumed the opposite. Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more…
-
Compounds this community declines to help with, and why Replied, post #61 · Compounds › Other compounds · 4 Oct 2025 · 6 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #24 · Compounds › Cagrilintide & amylin analogues · 1 Oct 2025 · 14 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: The mass-error checker and its intended scope Replied, post #22 · Data & Tools › Calculators · 22 Sep 2025 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #32 · Lounge › Off topic · 12 Sep 2025 · 8 likes post #31 is right about the mechanism and I think understates the practical bit. Industry and supply chain: post about manufacturing, pharmaceutical economics, or…
-
Hepatic impairment and the absence of data Replied, post #31 · Clinical › Special populations · 10 Sep 2025 · 1 like Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal impairment. Consulting with a clinician familiar…
-
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #36 · Evidence › Preprints · 22 Aug 2025 · 7 likes I read post #34 twice before replying, because I had assumed the opposite. Peer review as a filter: published papers have survived a review process that rejects many…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #86 · Access › Insurance & coverage · 19 Aug 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #25 · Practice › Administration · 19 Aug 2025 · 0 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #28 · Compounds › Tirzepatide · 18 Aug 2025 · 27 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #74 · Evidence › Trials · 15 Aug 2025 · 3 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #60 · Clinical › Special populations · 14 Aug 2025 · 3 likes This follows post #57 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
A ten-fold dose error caught before injection — one year on Replied, post #112 · Devices › Syringes & needles · 4 Aug 2025 · 13 likes Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer). Longer needles are needed for deeper tissue or if…
-
Thyroid function tests during substantial weight change Replied, post #20 · Clinical › Bloodwork · 3 Aug 2025 · 2 likes This follows post #17 rather than contradicting it. TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If…
-
The C-cell question: rodent findings and their human context Replied, post #45 · Compounds › Semaglutide · 31 Jul 2025 · 2 likes post #44 is right about the mechanism and I think understates the practical bit. Albumin binding is not a unique structural feature and nothing in the class lacks it,…
-
Request: a diff view for wiki revisions — the long version Replied, post #21 · Meta › Feature requests · 21 Jul 2025 · 0 likes Picking up post #18: that is the part I would want checked first. Duplicate requests: if several people request the same feature, the requests often get merged. Check…
-
A field-by-field walk through a certificate of analysis Replied, post #47 · Analytics › COA interpretation · 15 Jul 2025 · 33 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #76 · Compounds › Retatrutide · 8 Jul 2025 · 13 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
-
Reading a regulatory notice rather than an article about it — what changed since Replied, post #20 · Sourcing › Regulatory · 15 Jun 2025 · 4 likes Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #28 · Compounds › Semaglutide · 15 Jun 2025 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Half-life, steady state, and accumulation worked through Replied, post #103 · Pharmacology › Pharmacokinetics · 12 Jun 2025 · 10 likes SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently raises gastric pH and promotes absorption. Without it, oral…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #23 · Compounds › Cagrilintide & amylin analogues · 6 Jun 2025 · 29 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #47 · Evidence › Journal club · 28 May 2025 · 6 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #111 · Outcomes › Body composition · 28 May 2025 · 0 likes Visceral fat: DXA does not distinguish visceral (organ-associated) fat from subcutaneous fat. That distinction might matter but requires different imaging to measure.
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #31 · Meta › Wiki maintenance · 23 May 2025 · 4 likes Picking up post #28: that is the part I would want checked first. Cross-referencing: if two pages should reference each other but do not, suggesting the cross-reference…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #42 · Sourcing › Independent verification · 19 May 2025 · 26 likes post #41 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #51 · Practice › Reconstitution · 11 May 2025 · 2 likes Picking up post #48: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
A ten-fold dose error caught before injection Replied, post #27 · Devices › Syringes & needles · 29 Apr 2025 · 1 like Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #78 · Wellbeing › Mental health · 22 Apr 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Carryover and the ghost peak from last week's standard Replied, post #39 · Analytics › HPLC & UHPLC · 6 Apr 2025 · 0 likes Coming back to post #37, because the follow-up matters more than the original answer. On integration: where the baseline is drawn matters more than most people realise.…
-
Adjudicated events and why the definition matters — the long version Replied, post #70 · Evidence › Trials · 29 Mar 2025 · 9 likes post #69 is right about the mechanism and I think understates the practical bit. Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #30 · Compounds › Cagrilintide & amylin analogues · 25 Mar 2025 · 0 likes For anyone arriving from searches on "amylin agonist": this subcategory discusses published clinical evidence and what it does and does not establish. It does not…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #108 · Compounds › Semaglutide · 19 Mar 2025 · 32 likes post #107 is right about the mechanism and I think understates the practical bit. The opalescent appearance in semaglutide solutions is occasionally noted and the…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #86 · Pharmacology › Receptor biology · 12 Mar 2025 · 1 like Worth separating two things that post #82 runs together. Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class…
-
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #23 · Evidence › Journal club · 4 Mar 2025 · 5 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #7 · Sourcing › Regulatory · 27 Feb 2025 · 0 likes Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #42 · Evidence › Journal club · 15 Feb 2025 · 1 like SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Transit times by route, from a logged dataset — the long version Replied, post #55 · Sourcing › Logistics · 1 Feb 2025 · 18 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Canadian access and provincial variation Replied, post #26 · Regional › North America · 27 Jan 2025 · 3 likes Compounding pharmacies: pharmaceutical compounding of a drug not on the FDA shortage list is substantially constrained. The landscape changed when supply normalised.…
-
Revisiting: Holding a dose indefinitely: is there a documented downside? Replied, post #31 · Practice › Dosing & titration · 26 Jan 2025 · 12 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…
-
When "no data" is the complete and final answer Replied, post #74 · Compounds › Other compounds · 24 Jan 2025 · 0 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #19 · Documentation › Doc review · 28 Dec 2024 · 4 likes Fact-checking: if you see a factual claim in a maintained page that you have evidence contradicts, post the evidence here. The maintainer will review and correct if you…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #68 · Compounds › Semaglutide · 22 Dec 2024 · 1 like On post #64 — agreed on the reasoning, with one qualification. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A…
-
Fixed versus detachable needles: the trade-offs Replied, post #63 · Devices › Syringes & needles · 21 Dec 2024 · 0 likes post #62 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #15 · Nutrition & Training › Protein & intake · 21 Nov 2024 · 28 likes Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant sources require higher volume. Neither is nutritionally…
-
Taste changes and food aversion, reported and discussed Replied, post #43 · Practice › Side effects · 21 Nov 2024 · 17 likes Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek help are different. Occasional vomiting during…
-
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #40 · Sourcing › Independent verification · 21 Nov 2024 · 30 likes I read post #38 twice before replying, because I had assumed the opposite. Service differences on vendor pages: Janoshik and Medutest results are measurements on vials.…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #146 · Clinical › Bloodwork · 26 Oct 2024 · 13 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Food noise reducing and the disorientation that can follow Replied, post #9 · Wellbeing › Mental health · 19 Sep 2024 · 31 likes Disordered eating history: a history of anorexia, bulimia, or other eating disorders changes the risk-benefit calculation. Appetite suppression might trigger relapse.…
-
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #13 · Practice › Side effects · 10 Sep 2024 · 22 likes On post #9 — agreed on the reasoning, with one qualification. Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #7 · Compounds › Secretagogues & GH axis · 27 Aug 2024 · 31 likes Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is the only compound in this class with a registration-quality evidence base from a proper…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #25 · Devices › Syringes & needles · 24 Aug 2024 · 7 likes Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer). Longer needles are needed for deeper tissue or if…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #40 · Nutrition & Training › Hydration & electrolytes · 14 Aug 2024 · 2 likes Potassium: similar to sodium; losing weight involves some potassium loss. Bananas, sweet potatoes, and other potassium-rich foods help. Severe depletion is rare but…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #96 · Compounds › Retatrutide · 22 Jul 2024 · 20 likes I read post #94 twice before replying, because I had assumed the opposite. How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range…
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #62 · Practice › Interactions · 17 Jul 2024 · 16 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
The topic list is dense — is that deliberate? Replied, post #3 · Meta › Site feedback · 8 Jul 2024 · 0 likes Performance: if pages are slow to load, timeouts occur, or the site is unresponsive, that is worth reporting with details (when, which pages, how slow).
-
Cold packs, phase-change material, and what survives ten days Replied, post #81 · Sourcing › Logistics · 7 Jul 2024 · 0 likes On post #77 — agreed on the reasoning, with one qualification. Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that…
-
Assessing a warm arrival: the decision process — one year on Replied, post #45 · Sourcing › Logistics · 30 May 2024 · 19 likes I read post #43 twice before replying, because I had assumed the opposite. Insurance and carrier liability: most parcel carriers limit liability. Understanding the…